CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
41.47 0.07(0.17%) NAV as on 30 Jul 2025
5.28 % 1 M
17.05 % 1 Y
29.5 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.89

As on 30 Jun, 2025
age-icon Age :

7 yrs 0 m

Since 13 07 ,2018
exit_load Exit Load :

1%

aum AUM :

5,727.59 Crs

lock_in Lock-in :

1% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

5.71

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dharmesh Kakkad

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jun 30 ,2025
Others 3.55 %
Equity 96.45 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.23 %
Divi's Laboratories Ltd.8.95 %
Dr. Reddy's Laboratories Ltd.8.92 %
Cipla Ltd.7.75 %
Aurobindo Pharma Ltd.6.06 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs84.38
Business Support6.00
Hospital & Healthcare Services3.70
Chemicals1.29
Insurance1.08
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)17.3519.6918.6430.2036.20
Net Assets(Rs Crores) (as on 31-Mar-2025) 2213.63 2500.42 2594.59 3772.32 4914.64
Scheme Returns(%)(Absolute)83.7912.51-5.3861.1518.22
B'mark Returns(%)(Absolute)NANANANANA
Category Rank19/7547/7563/7612/906/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.470.07(0.17%)NAV As on 30 Jul, 202513-Jul-2018Inception Date5,727.59AUM In Cr.17.05%1Y29.50%3Y23.89%5Y22.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity444.965.06(1.15%)NAV As on 30 Jul, 202514-Jul-1999Inception Date3,849.24AUM In Cr.16.99%1Y28.30%3Y23.68%5Y16.41%Since Inception
Nippon India Pharma Fund(G)Very HighEquity536.811.25(0.23%)NAV As on 30 Jul, 202505-Jun-2004Inception Date8,569.15AUM In Cr.10.90%1Y24.95%3Y21.24%5Y20.71%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.390.16(0.52%)NAV As on 30 Jul, 202528-Dec-2015Inception Date1,281.99AUM In Cr.9.88%1Y24.31%3Y21.03%5Y12.66%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.